

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.25516743 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.81507022 |
| 3 | muscle filament sliding (GO:0030049) | 7.81507022 |
| 4 | regulation of relaxation of muscle (GO:1901077) | 7.53906712 |
| 5 | skeletal muscle contraction (GO:0003009) | 6.99317708 |
| 6 | actin-mediated cell contraction (GO:0070252) | 6.71501174 |
| 7 | skeletal muscle adaptation (GO:0043501) | 6.51875266 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.51507474 |
| 9 | skeletal muscle fiber development (GO:0048741) | 5.67308758 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.50827420 |
| 11 | myotube cell development (GO:0014904) | 5.29841781 |
| 12 | actin filament-based movement (GO:0030048) | 4.84491245 |
| 13 | cardiac myofibril assembly (GO:0055003) | 4.74761638 |
| 14 | glycogen catabolic process (GO:0005980) | 4.72029851 |
| 15 | skeletal muscle tissue regeneration (GO:0043403) | 4.68766384 |
| 16 | cardiac muscle contraction (GO:0060048) | 4.57707877 |
| 17 | purine nucleotide salvage (GO:0032261) | 4.56864358 |
| 18 | glucan catabolic process (GO:0009251) | 4.34329587 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.24307727 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 4.23425760 |
| 21 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.22085399 |
| 22 | striated muscle contraction (GO:0006941) | 4.20231025 |
| 23 | muscle cell fate commitment (GO:0042693) | 4.14558877 |
| 24 | regulation of cell communication by electrical coupling (GO:0010649) | 4.14544525 |
| 25 | NADH metabolic process (GO:0006734) | 4.11000426 |
| 26 | cellular polysaccharide catabolic process (GO:0044247) | 4.09055826 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.07429430 |
| 28 | cardiac muscle hypertrophy (GO:0003300) | 4.07024514 |
| 29 | response to pheromone (GO:0019236) | 4.00603901 |
| 30 | fructose metabolic process (GO:0006000) | 3.99486615 |
| 31 | response to gravity (GO:0009629) | 3.97341765 |
| 32 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.91320136 |
| 33 | otic vesicle formation (GO:0030916) | 3.89196779 |
| 34 | polysaccharide catabolic process (GO:0000272) | 3.88914678 |
| 35 | striated muscle hypertrophy (GO:0014897) | 3.88078810 |
| 36 | plasma membrane repair (GO:0001778) | 3.85041203 |
| 37 | gluconeogenesis (GO:0006094) | 3.84846765 |
| 38 | myofibril assembly (GO:0030239) | 3.84698595 |
| 39 | muscle contraction (GO:0006936) | 3.83930946 |
| 40 | IMP metabolic process (GO:0046040) | 3.83225142 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.83018840 |
| 42 | muscle hypertrophy (GO:0014896) | 3.77896510 |
| 43 | notochord development (GO:0030903) | 3.64685236 |
| 44 | response to muscle activity (GO:0014850) | 3.62595976 |
| 45 | striated muscle atrophy (GO:0014891) | 3.62053595 |
| 46 | AMP metabolic process (GO:0046033) | 3.61734509 |
| 47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.60172439 |
| 48 | striated muscle adaptation (GO:0014888) | 3.57111312 |
| 49 | muscle tissue morphogenesis (GO:0060415) | 3.53409953 |
| 50 | hexose biosynthetic process (GO:0019319) | 3.51055963 |
| 51 | muscle fiber development (GO:0048747) | 3.50684921 |
| 52 | neuromuscular synaptic transmission (GO:0007274) | 3.50288987 |
| 53 | sarcomere organization (GO:0045214) | 3.49064639 |
| 54 | tricarboxylic acid cycle (GO:0006099) | 3.48287318 |
| 55 | muscle system process (GO:0003012) | 3.42405486 |
| 56 | muscle cell cellular homeostasis (GO:0046716) | 3.41912562 |
| 57 | myotube differentiation (GO:0014902) | 3.41305418 |
| 58 | carnitine shuttle (GO:0006853) | 3.41268514 |
| 59 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.39723168 |
| 60 | regulation of sequestering of triglyceride (GO:0010889) | 3.38764556 |
| 61 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.37547949 |
| 62 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36376618 |
| 63 | muscle organ morphogenesis (GO:0048644) | 3.35775152 |
| 64 | muscle cell development (GO:0055001) | 3.35295232 |
| 65 | regulation of striated muscle contraction (GO:0006942) | 3.35044115 |
| 66 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.34667264 |
| 67 | IMP biosynthetic process (GO:0006188) | 3.34405892 |
| 68 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.32326121 |
| 69 | ubiquinone biosynthetic process (GO:0006744) | 3.31094144 |
| 70 | cardiac muscle cell development (GO:0055013) | 3.30916937 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.29386265 |
| 72 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.29063080 |
| 73 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.29063080 |
| 74 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.28420903 |
| 75 | paraxial mesoderm development (GO:0048339) | 3.21932774 |
| 76 | adult heart development (GO:0007512) | 3.19699953 |
| 77 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.19450886 |
| 78 | fatty acid transmembrane transport (GO:1902001) | 3.18480608 |
| 79 | protein localization to synapse (GO:0035418) | 3.16164985 |
| 80 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.15561581 |
| 81 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.15561581 |
| 82 | glycogen biosynthetic process (GO:0005978) | 3.15522926 |
| 83 | glucan biosynthetic process (GO:0009250) | 3.15522926 |
| 84 | potassium ion import (GO:0010107) | 3.14533758 |
| 85 | heart process (GO:0003015) | 3.13537951 |
| 86 | heart contraction (GO:0060047) | 3.13537951 |
| 87 | myoblast fusion (GO:0007520) | 3.12597151 |
| 88 | muscle organ development (GO:0007517) | 3.09474993 |
| 89 | negative regulation of muscle contraction (GO:0045932) | 3.07023444 |
| 90 | retinal rod cell development (GO:0046548) | 3.06031901 |
| 91 | cardiac cell development (GO:0055006) | 3.05132875 |
| 92 | galactose catabolic process (GO:0019388) | 3.04983269 |
| 93 | cardiac muscle adaptation (GO:0014887) | 3.04714497 |
| 94 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.04714497 |
| 95 | muscle hypertrophy in response to stress (GO:0003299) | 3.04714497 |
| 96 | muscle structure development (GO:0061061) | 3.04580131 |
| 97 | response to inactivity (GO:0014854) | 3.02763673 |
| 98 | regulation of cofactor metabolic process (GO:0051193) | 3.02077665 |
| 99 | regulation of coenzyme metabolic process (GO:0051196) | 3.02077665 |
| 100 | positive regulation of myotube differentiation (GO:0010831) | 3.01827743 |
| 101 | monosaccharide biosynthetic process (GO:0046364) | 3.00766277 |
| 102 | cell aggregation (GO:0098743) | 3.00040023 |
| 103 | cartilage condensation (GO:0001502) | 3.00040023 |
| 104 | ubiquinone metabolic process (GO:0006743) | 2.99690222 |
| 105 | muscle atrophy (GO:0014889) | 2.98632987 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 2.97754637 |
| 107 | actomyosin structure organization (GO:0031032) | 2.96228229 |
| 108 | calcium ion import (GO:0070509) | 2.96003255 |
| 109 | regulation of membrane repolarization (GO:0060306) | 2.92898955 |
| 110 | sialylation (GO:0097503) | 2.92070936 |
| 111 | creatine metabolic process (GO:0006600) | 2.90536117 |
| 112 | syncytium formation (GO:0006949) | 2.89138525 |
| 113 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.86889392 |
| 114 | positive regulation of myoblast differentiation (GO:0045663) | 2.79149420 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72246299 |
| 116 | glycolytic process (GO:0006096) | 2.72164042 |
| 117 | muscle adaptation (GO:0043500) | 2.72069838 |
| 118 | cardiac muscle cell action potential (GO:0086001) | 2.71999445 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.71247822 |
| 120 | neuromuscular junction development (GO:0007528) | 2.69244901 |
| 121 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.66551375 |
| 122 | protein hydroxylation (GO:0018126) | 2.65480820 |
| 123 | cerebellar granule cell differentiation (GO:0021707) | 2.64128321 |
| 124 | C4-dicarboxylate transport (GO:0015740) | 2.64020174 |
| 125 | cellular carbohydrate catabolic process (GO:0044275) | 2.61612321 |
| 126 | glycogen metabolic process (GO:0005977) | 2.58946302 |
| 127 | response to activity (GO:0014823) | 2.58768337 |
| 128 | outer ear morphogenesis (GO:0042473) | 2.58479155 |
| 129 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.57978007 |
| 130 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.53926290 |
| 131 | regulation of cardioblast proliferation (GO:0003264) | 2.53926290 |
| 132 | regulation of meiosis I (GO:0060631) | 2.53875413 |
| 133 | skeletal muscle tissue development (GO:0007519) | 2.52943972 |
| 134 | striated muscle cell development (GO:0055002) | 2.52844935 |
| 135 | cytoplasmic microtubule organization (GO:0031122) | 2.51782229 |
| 136 | glucan metabolic process (GO:0044042) | 2.51306642 |
| 137 | cellular glucan metabolic process (GO:0006073) | 2.51306642 |
| 138 | postsynaptic membrane organization (GO:0001941) | 2.51040624 |
| 139 | regulation of myoblast differentiation (GO:0045661) | 2.48668145 |
| 140 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.46969227 |
| 141 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.44216245 |
| 142 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.44194248 |
| 143 | cytidine catabolic process (GO:0006216) | 2.42670102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.86643899 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.14249661 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.55326977 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.91159058 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60412511 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53231289 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.49384774 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31685902 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28031747 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26055478 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.24196840 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.24196840 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.20853559 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17304796 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13559594 |
| 16 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.02264791 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99588624 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99237024 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.98604315 |
| 20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.94013171 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93170011 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91898234 |
| 23 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.91634787 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.91496307 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.90823213 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90168759 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90168759 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89448541 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88734682 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87390288 |
| 31 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.85971099 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84011329 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83053309 |
| 34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80763240 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78283883 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71510869 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71438442 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.71415712 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67244588 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.65470282 |
| 41 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.63361452 |
| 42 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.62921715 |
| 43 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.62576821 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61579410 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60707978 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58875587 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.57416601 |
| 48 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55508552 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54849256 |
| 50 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54723471 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54017324 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53401718 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52944293 |
| 54 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51468701 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49644424 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49079577 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47593590 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45839640 |
| 59 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43642837 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42063092 |
| 61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41843543 |
| 62 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41235605 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41129290 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40649876 |
| 65 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34246715 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32480397 |
| 67 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.32349553 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31887125 |
| 69 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30037548 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.29764763 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.24134448 |
| 72 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23889338 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22927914 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22186877 |
| 75 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19972195 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19542286 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19306502 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17120775 |
| 79 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16732483 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16468401 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16447092 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16352449 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16352449 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15033514 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14161390 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13819765 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13819765 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13113612 |
| 89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11630826 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10393816 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09334815 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09248641 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09226135 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08228552 |
| 95 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07432564 |
| 96 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07223876 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06882424 |
| 98 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04793591 |
| 99 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04720839 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03795992 |
| 101 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.02797398 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01955667 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00975135 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00446056 |
| 105 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00446056 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99827710 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99544018 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99218335 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97976040 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97869622 |
| 111 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97769856 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97365640 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96907417 |
| 114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96562565 |
| 115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96297222 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96165903 |
| 117 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95694853 |
| 118 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95295617 |
| 119 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.95106953 |
| 120 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94818864 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94154824 |
| 122 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93450440 |
| 123 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.93421619 |
| 124 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.93421619 |
| 125 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.93421619 |
| 126 | AR_19668381_ChIP-Seq_PC3_Human | 0.92705069 |
| 127 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92539268 |
| 128 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91427089 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91133998 |
| 130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91093511 |
| 131 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90217866 |
| 132 | JUN_21703547_ChIP-Seq_K562_Human | 0.89507116 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89346649 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89177985 |
| 135 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88872516 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87155077 |
| 137 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.86673135 |
| 138 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86663325 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86053791 |
| 140 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85618921 |
| 141 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85618921 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85300918 |
| 143 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84809476 |
| 144 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.84689118 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84419435 |
| 146 | NFYB_21822215_ChIP-Seq_K562_Human | 0.83540531 |
| 147 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83525717 |
| 148 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83385409 |
| 149 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.82322650 |
| 150 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82117927 |
| 151 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.81484961 |
| 152 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.80359793 |
| 153 | CBP_21632823_ChIP-Seq_H3396_Human | 0.80065167 |
| 154 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79392364 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78679533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.27800463 |
| 2 | MP0003646_muscle_fatigue | 5.39291745 |
| 3 | MP0000749_muscle_degeneration | 4.57343756 |
| 4 | MP0000751_myopathy | 4.37859460 |
| 5 | MP0000747_muscle_weakness | 3.14175938 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.00974950 |
| 7 | MP0004233_abnormal_muscle_weight | 2.88216223 |
| 8 | MP0000759_abnormal_skeletal_muscle | 2.85587313 |
| 9 | MP0000750_abnormal_muscle_regeneration | 2.81602756 |
| 10 | MP0005451_abnormal_body_composition | 2.79744026 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.76566923 |
| 12 | MP0005369_muscle_phenotype | 2.69452847 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.55834417 |
| 14 | MP0002269_muscular_atrophy | 2.52347845 |
| 15 | MP0002108_abnormal_muscle_morphology | 2.41365941 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.17602848 |
| 17 | MP0009250_abnormal_appendicular_skeleto | 2.17341447 |
| 18 | MP0002332_abnormal_exercise_endurance | 1.96847850 |
| 19 | MP0004130_abnormal_muscle_cell | 1.91669301 |
| 20 | MP0000733_abnormal_muscle_development | 1.82430570 |
| 21 | MP0010030_abnormal_orbit_morphology | 1.78392436 |
| 22 | MP0005503_abnormal_tendon_morphology | 1.71697658 |
| 23 | MP0004215_abnormal_myocardial_fiber | 1.67492192 |
| 24 | MP0003941_abnormal_skin_development | 1.65728190 |
| 25 | MP0000762_abnormal_tongue_morphology | 1.64422445 |
| 26 | MP0004134_abnormal_chest_morphology | 1.59713628 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.52462804 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.50788605 |
| 29 | MP0004270_analgesia | 1.45794399 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.42470477 |
| 31 | MP0010630_abnormal_cardiac_muscle | 1.41982153 |
| 32 | MP0000049_abnormal_middle_ear | 1.38813915 |
| 33 | MP0001346_abnormal_lacrimal_gland | 1.37817410 |
| 34 | MP0001661_extended_life_span | 1.33673642 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.33012359 |
| 36 | MP0002089_abnormal_postnatal_growth/wei | 1.30960069 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.26117786 |
| 38 | MP0003755_abnormal_palate_morphology | 1.21266712 |
| 39 | MP0001544_abnormal_cardiovascular_syste | 1.17625985 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.17625985 |
| 41 | MP0003137_abnormal_impulse_conducting | 1.11545532 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.10223873 |
| 43 | MP0000163_abnormal_cartilage_morphology | 1.09296842 |
| 44 | MP0006138_congestive_heart_failure | 1.08740577 |
| 45 | MP0004484_altered_response_of | 1.08434474 |
| 46 | MP0004859_abnormal_synaptic_plasticity | 1.07160434 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.07149995 |
| 48 | MP0005666_abnormal_adipose_tissue | 1.06874236 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.03812358 |
| 50 | MP0004043_abnormal_pH_regulation | 1.02601866 |
| 51 | MP0002249_abnormal_larynx_morphology | 1.02059694 |
| 52 | MP0005670_abnormal_white_adipose | 1.01872305 |
| 53 | MP0000631_abnormal_neuroendocrine_gland | 1.01723312 |
| 54 | MP0001299_abnormal_eye_distance/ | 1.01479421 |
| 55 | MP0003880_abnormal_central_pattern | 1.01193361 |
| 56 | MP0002127_abnormal_cardiovascular_syste | 1.00774460 |
| 57 | MP0000566_synostosis | 1.00740820 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00149654 |
| 59 | MP0005508_abnormal_skeleton_morphology | 0.98184682 |
| 60 | MP0008004_abnormal_stomach_pH | 0.98015147 |
| 61 | MP0004510_myositis | 0.97029731 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 0.97026939 |
| 63 | MP0002115_abnormal_skeleton_extremities | 0.96125012 |
| 64 | MP0002896_abnormal_bone_mineralization | 0.94777204 |
| 65 | MP0005275_abnormal_skin_tensile | 0.94625370 |
| 66 | MP0001542_abnormal_bone_strength | 0.93533081 |
| 67 | MP0002233_abnormal_nose_morphology | 0.92900641 |
| 68 | MP0000372_irregular_coat_pigmentation | 0.91270344 |
| 69 | MP0002109_abnormal_limb_morphology | 0.90548325 |
| 70 | MP0002116_abnormal_craniofacial_bone | 0.89039997 |
| 71 | MP0003879_abnormal_hair_cell | 0.89028737 |
| 72 | MP0000678_abnormal_parathyroid_gland | 0.88622579 |
| 73 | MP0005623_abnormal_meninges_morphology | 0.86610153 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.85618869 |
| 75 | MP0005330_cardiomyopathy | 0.85418761 |
| 76 | MP0002114_abnormal_axial_skeleton | 0.84095482 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.83002391 |
| 78 | MP0002972_abnormal_cardiac_muscle | 0.82605006 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 0.81192156 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.80932388 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.79909623 |
| 82 | MP0004147_increased_porphyrin_level | 0.79760367 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.79346186 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 0.76359592 |
| 85 | MP0001486_abnormal_startle_reflex | 0.76144111 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.73582330 |
| 87 | MP0000432_abnormal_head_morphology | 0.71196735 |
| 88 | MP0002282_abnormal_trachea_morphology | 0.71194266 |
| 89 | MP0003635_abnormal_synaptic_transmissio | 0.70605863 |
| 90 | MP0000534_abnormal_ureter_morphology | 0.70123713 |
| 91 | MP0001984_abnormal_olfaction | 0.69195928 |
| 92 | MP0002113_abnormal_skeleton_development | 0.69080062 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.66989363 |
| 94 | MP0008260_abnormal_autophagy | 0.66854827 |
| 95 | MP0005171_absent_coat_pigmentation | 0.66608780 |
| 96 | MP0003279_aneurysm | 0.66275338 |
| 97 | MP0005266_abnormal_metabolism | 0.65646967 |
| 98 | MP0005646_abnormal_pituitary_gland | 0.64551851 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.64012451 |
| 100 | MP0000266_abnormal_heart_morphology | 0.63770436 |
| 101 | MP0003385_abnormal_body_wall | 0.63715581 |
| 102 | MP0002932_abnormal_joint_morphology | 0.63703616 |
| 103 | MP0000428_abnormal_craniofacial_morphol | 0.62770499 |
| 104 | MP0009697_abnormal_copulation | 0.60994492 |
| 105 | MP0001270_distended_abdomen | 0.60271336 |
| 106 | MP0004142_abnormal_muscle_tone | 0.60176537 |
| 107 | MP0004085_abnormal_heartbeat | 0.59552887 |
| 108 | MP0003011_delayed_dark_adaptation | 0.59471807 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.58882964 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.58738372 |
| 111 | MP0003935_abnormal_craniofacial_develop | 0.57669612 |
| 112 | MP0003938_abnormal_ear_development | 0.56977492 |
| 113 | MP0009672_abnormal_birth_weight | 0.56508825 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.55629079 |
| 115 | MP0002971_abnormal_brown_adipose | 0.55175828 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.54605493 |
| 117 | MP0005375_adipose_tissue_phenotype | 0.52761572 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.52636288 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.51818541 |
| 120 | MP0003959_abnormal_lean_body | 0.51436445 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.50716154 |
| 122 | MP0003942_abnormal_urinary_system | 0.48858954 |
| 123 | MP0003136_yellow_coat_color | 0.48097511 |
| 124 | MP0005332_abnormal_amino_acid | 0.47540406 |
| 125 | MP0003045_fibrosis | 0.46146881 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.45728363 |
| 127 | MP0005452_abnormal_adipose_tissue | 0.44909938 |
| 128 | MP0008569_lethality_at_weaning | 0.44436374 |
| 129 | MP0005376_homeostasis/metabolism_phenot | 0.42196534 |
| 130 | MP0002822_catalepsy | 0.38800215 |
| 131 | MP0005334_abnormal_fat_pad | 0.38186948 |
| 132 | MP0005535_abnormal_body_temperature | 0.37710964 |
| 133 | MP0002128_abnormal_blood_circulation | 0.37190135 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36688466 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.35233742 |
| 136 | MP0002734_abnormal_mechanical_nocicepti | 0.33965869 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.33480570 |
| 138 | MP0005187_abnormal_penis_morphology | 0.32468091 |
| 139 | MP0004197_abnormal_fetal_growth/weight/ | 0.28757748 |
| 140 | MP0003828_pulmonary_edema | 0.28752425 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.28246467 |
| 142 | MP0009703_decreased_birth_body | 0.26420907 |
| 143 | MP0004272_abnormal_basement_membrane | 0.26184401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.77755565 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.48150260 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.23625137 |
| 4 | Nemaline bodies (HP:0003798) | 7.01242352 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.30242187 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 6.15251604 |
| 7 | Round ear (HP:0100830) | 5.72063385 |
| 8 | Myopathic facies (HP:0002058) | 5.50805055 |
| 9 | Distal arthrogryposis (HP:0005684) | 5.43747272 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 5.30075589 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.02570093 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 4.41501393 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.24088245 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.14848788 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 4.12758653 |
| 16 | Absent phalangeal crease (HP:0006109) | 3.93559236 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.82602149 |
| 18 | Myoglobinuria (HP:0002913) | 3.81992731 |
| 19 | Deformed tarsal bones (HP:0008119) | 3.75891318 |
| 20 | Shoulder girdle muscle weakness (HP:0003547) | 3.57650453 |
| 21 | Difficulty running (HP:0009046) | 3.56036996 |
| 22 | Hypoplastic ischia (HP:0003175) | 3.55268411 |
| 23 | Muscle stiffness (HP:0003552) | 3.38257023 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.34415449 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 3.31359562 |
| 26 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.26532671 |
| 27 | Increased connective tissue (HP:0009025) | 3.21260007 |
| 28 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.15249887 |
| 29 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.15249887 |
| 30 | Pelvic girdle muscle weakness (HP:0003749) | 3.12984919 |
| 31 | Septo-optic dysplasia (HP:0100842) | 3.11377909 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.09359313 |
| 33 | Abnormality of the ischium (HP:0003174) | 3.06524515 |
| 34 | Myotonia (HP:0002486) | 2.95027009 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.87720600 |
| 36 | Hyporeflexia of lower limbs (HP:0002600) | 2.80035457 |
| 37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.78757411 |
| 38 | Waddling gait (HP:0002515) | 2.77860721 |
| 39 | Metaphyseal cupping (HP:0003021) | 2.76467533 |
| 40 | Sudden death (HP:0001699) | 2.74615079 |
| 41 | Rimmed vacuoles (HP:0003805) | 2.71739044 |
| 42 | Abnormality of the calcaneus (HP:0008364) | 2.68469707 |
| 43 | Focal motor seizures (HP:0011153) | 2.67484830 |
| 44 | Neck muscle weakness (HP:0000467) | 2.63781860 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 2.59074145 |
| 46 | Hyperkalemia (HP:0002153) | 2.58483489 |
| 47 | Hip contracture (HP:0003273) | 2.56627324 |
| 48 | Bulbar palsy (HP:0001283) | 2.51112169 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.50079551 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.49034493 |
| 51 | Dilated cardiomyopathy (HP:0001644) | 2.44508325 |
| 52 | Bundle branch block (HP:0011710) | 2.38672108 |
| 53 | Weak cry (HP:0001612) | 2.37193554 |
| 54 | Malignant hyperthermia (HP:0002047) | 2.36840366 |
| 55 | Slender build (HP:0001533) | 2.34140447 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.32721682 |
| 57 | Nonprogressive disorder (HP:0003680) | 2.29150785 |
| 58 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.28197642 |
| 59 | Limb-girdle muscle weakness (HP:0003325) | 2.24926396 |
| 60 | Muscular dystrophy (HP:0003560) | 2.24266448 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.23095832 |
| 62 | Frequent falls (HP:0002359) | 2.19558936 |
| 63 | Irregular epiphyses (HP:0010582) | 2.18861975 |
| 64 | Limited hip movement (HP:0008800) | 2.16805627 |
| 65 | Subaortic stenosis (HP:0001682) | 2.16319966 |
| 66 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.16319966 |
| 67 | Metaphyseal dysplasia (HP:0100255) | 2.16079882 |
| 68 | Neonatal short-limb short stature (HP:0008921) | 2.14395677 |
| 69 | Mesomelia (HP:0003027) | 2.13009890 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 2.09493874 |
| 71 | Increased purine levels (HP:0004368) | 2.09445891 |
| 72 | Hyperuricemia (HP:0002149) | 2.09445891 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.09033203 |
| 74 | Progressive muscle weakness (HP:0003323) | 2.08118553 |
| 75 | Lipoatrophy (HP:0100578) | 2.04688103 |
| 76 | Spinal rigidity (HP:0003306) | 2.04105858 |
| 77 | Proximal amyotrophy (HP:0007126) | 1.96522850 |
| 78 | Epileptic encephalopathy (HP:0200134) | 1.94685393 |
| 79 | Long clavicles (HP:0000890) | 1.93974263 |
| 80 | Ventricular tachycardia (HP:0004756) | 1.93171030 |
| 81 | Genu varum (HP:0002970) | 1.92202135 |
| 82 | Flat capital femoral epiphysis (HP:0003370) | 1.90164708 |
| 83 | Abnormality of the pubic bones (HP:0003172) | 1.88769674 |
| 84 | Exercise intolerance (HP:0003546) | 1.85803773 |
| 85 | Mild short stature (HP:0003502) | 1.85370005 |
| 86 | Short palpebral fissure (HP:0012745) | 1.83521766 |
| 87 | Cupped ribs (HP:0000887) | 1.82827230 |
| 88 | Epiphyseal dysplasia (HP:0002656) | 1.82461078 |
| 89 | Wrist flexion contracture (HP:0001239) | 1.81466905 |
| 90 | Fatigable weakness (HP:0003473) | 1.80832412 |
| 91 | Abnormality of the neuromuscular junction (HP:0003398) | 1.80832412 |
| 92 | Scapular winging (HP:0003691) | 1.80161585 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79233710 |
| 94 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.78182601 |
| 95 | Lower limb amyotrophy (HP:0007210) | 1.77053968 |
| 96 | EMG: neuropathic changes (HP:0003445) | 1.76151685 |
| 97 | Fibular aplasia (HP:0002990) | 1.71859174 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 1.70726861 |
| 99 | Popliteal pterygium (HP:0009756) | 1.69311389 |
| 100 | Bell-shaped thorax (HP:0001591) | 1.68969221 |
| 101 | Optic nerve hypoplasia (HP:0000609) | 1.68685603 |
| 102 | Tarsal synostosis (HP:0008368) | 1.68413518 |
| 103 | Gowers sign (HP:0003391) | 1.68097850 |
| 104 | Absence seizures (HP:0002121) | 1.67888849 |
| 105 | Vitreoretinal degeneration (HP:0000655) | 1.66817127 |
| 106 | Type 2 muscle fiber atrophy (HP:0003554) | 1.63413635 |
| 107 | Febrile seizures (HP:0002373) | 1.63387987 |
| 108 | Gout (HP:0001997) | 1.62915135 |
| 109 | Absent septum pellucidum (HP:0001331) | 1.62438282 |
| 110 | Generalized muscle weakness (HP:0003324) | 1.61816777 |
| 111 | Atonic seizures (HP:0010819) | 1.58473443 |
| 112 | Ulnar deviation of finger (HP:0009465) | 1.58033313 |
| 113 | Irregular vertebral endplates (HP:0003301) | 1.58008144 |
| 114 | Facial diplegia (HP:0001349) | 1.57147635 |
| 115 | Broad-based gait (HP:0002136) | 1.57147260 |
| 116 | Abnormality of the vertebral endplates (HP:0005106) | 1.56848426 |
| 117 | Heart block (HP:0012722) | 1.55998924 |
| 118 | Foot dorsiflexor weakness (HP:0009027) | 1.55572368 |
| 119 | Paralysis (HP:0003470) | 1.54383852 |
| 120 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.53086417 |
| 121 | Metatarsus adductus (HP:0001840) | 1.50451243 |
| 122 | Oligomenorrhea (HP:0000876) | 1.49723036 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.46954172 |
| 124 | Muscle fiber atrophy (HP:0100295) | 1.45271737 |
| 125 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.44566473 |
| 126 | Increased muscle lipid content (HP:0009058) | 1.44283049 |
| 127 | Abnormal atrioventricular conduction (HP:0005150) | 1.43523552 |
| 128 | Increased intramyocellular lipid droplets (HP:0012240) | 1.42762997 |
| 129 | Ragged-red muscle fibers (HP:0003200) | 1.38335407 |
| 130 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.28511487 |
| 131 | Steppage gait (HP:0003376) | 1.28352555 |
| 132 | Hypoalphalipoproteinemia (HP:0003233) | 1.27498201 |
| 133 | Abnormality of potassium homeostasis (HP:0011042) | 1.25312570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.54812079 |
| 2 | PHKG1 | 5.10643920 |
| 3 | PHKG2 | 5.10643920 |
| 4 | TTN | 4.26671865 |
| 5 | NME1 | 3.69958887 |
| 6 | CASK | 3.22860865 |
| 7 | NEK1 | 2.72902288 |
| 8 | STK38L | 2.52029473 |
| 9 | PINK1 | 2.35733645 |
| 10 | PIK3CG | 2.31229290 |
| 11 | CCNB1 | 2.04480644 |
| 12 | EPHA4 | 1.90148141 |
| 13 | PIK3CA | 1.81823799 |
| 14 | PDK2 | 1.73520622 |
| 15 | PAK6 | 1.65494076 |
| 16 | PDK3 | 1.64471646 |
| 17 | PDK4 | 1.64471646 |
| 18 | MAPK12 | 1.61107425 |
| 19 | TAOK2 | 1.53729418 |
| 20 | LATS2 | 1.52783099 |
| 21 | LATS1 | 1.51181599 |
| 22 | DDR2 | 1.49357085 |
| 23 | MAP2K3 | 1.45394130 |
| 24 | DMPK | 1.44850593 |
| 25 | MAP3K7 | 1.34788993 |
| 26 | EPHA2 | 1.34536786 |
| 27 | MAP3K3 | 1.29193990 |
| 28 | TAOK1 | 1.27286458 |
| 29 | AKT3 | 1.25444711 |
| 30 | MUSK | 1.19319793 |
| 31 | KSR1 | 1.17488084 |
| 32 | LIMK1 | 1.17332951 |
| 33 | ZAK | 1.12413351 |
| 34 | ACVR1B | 1.09984289 |
| 35 | BCKDK | 1.09328703 |
| 36 | PLK2 | 1.07906909 |
| 37 | MAP2K4 | 1.06580471 |
| 38 | STK24 | 1.04532369 |
| 39 | CDK19 | 1.04097434 |
| 40 | KSR2 | 1.02635847 |
| 41 | MOS | 0.99247089 |
| 42 | ERBB3 | 0.96388274 |
| 43 | RAF1 | 0.92530989 |
| 44 | PRKAA2 | 0.86811635 |
| 45 | MAPK7 | 0.83520931 |
| 46 | OXSR1 | 0.80552656 |
| 47 | NEK6 | 0.78581176 |
| 48 | CAMKK2 | 0.77950199 |
| 49 | CDK3 | 0.77019663 |
| 50 | CDK8 | 0.76755483 |
| 51 | PRKAA1 | 0.68416245 |
| 52 | NTRK3 | 0.66715772 |
| 53 | SGK2 | 0.65754098 |
| 54 | DYRK1B | 0.65497208 |
| 55 | MARK1 | 0.65166487 |
| 56 | STK3 | 0.63166957 |
| 57 | CAMK4 | 0.62742645 |
| 58 | CAMK2G | 0.62011162 |
| 59 | SGK1 | 0.61234105 |
| 60 | CAMK1 | 0.59047784 |
| 61 | TNIK | 0.58882530 |
| 62 | MAP3K11 | 0.58648585 |
| 63 | TIE1 | 0.57879441 |
| 64 | TGFBR2 | 0.54575816 |
| 65 | MKNK2 | 0.53820709 |
| 66 | FER | 0.53121934 |
| 67 | DYRK1A | 0.52098939 |
| 68 | AKT2 | 0.51382075 |
| 69 | PAK3 | 0.51046255 |
| 70 | PTK2B | 0.50232078 |
| 71 | PRKCG | 0.50226808 |
| 72 | MAP2K6 | 0.47003418 |
| 73 | WNK3 | 0.46413220 |
| 74 | FGFR1 | 0.44361418 |
| 75 | PRPF4B | 0.44356542 |
| 76 | CAMK2D | 0.43897151 |
| 77 | PBK | 0.42911469 |
| 78 | PKN1 | 0.42404971 |
| 79 | STK38 | 0.39545672 |
| 80 | MAPKAPK3 | 0.39303684 |
| 81 | BUB1 | 0.39125447 |
| 82 | ROCK1 | 0.38946045 |
| 83 | SGK3 | 0.37879218 |
| 84 | MAP3K5 | 0.35844617 |
| 85 | PLK3 | 0.35493631 |
| 86 | TRPM7 | 0.35110151 |
| 87 | MAP3K12 | 0.34969174 |
| 88 | ARAF | 0.34467145 |
| 89 | CAMK2A | 0.32441778 |
| 90 | PRKD3 | 0.31701448 |
| 91 | BRAF | 0.31247422 |
| 92 | MAP3K13 | 0.30870878 |
| 93 | EPHA3 | 0.30537570 |
| 94 | MAPK10 | 0.30381386 |
| 95 | PRKG1 | 0.30310254 |
| 96 | PRKACB | 0.30139634 |
| 97 | CAMK2B | 0.29765106 |
| 98 | PRKACA | 0.29308125 |
| 99 | DYRK3 | 0.28504942 |
| 100 | TTK | 0.27998331 |
| 101 | RPS6KB1 | 0.27796316 |
| 102 | RPS6KA3 | 0.27190765 |
| 103 | PRKCE | 0.26558399 |
| 104 | RPS6KB2 | 0.26408664 |
| 105 | MST4 | 0.25150769 |
| 106 | MARK2 | 0.24973703 |
| 107 | LMTK2 | 0.24907893 |
| 108 | INSRR | 0.24801755 |
| 109 | MAP2K1 | 0.24279661 |
| 110 | MAPK4 | 0.24181817 |
| 111 | EEF2K | 0.23735532 |
| 112 | SGK494 | 0.23664084 |
| 113 | SGK223 | 0.23664084 |
| 114 | DAPK2 | 0.23645725 |
| 115 | NEK9 | 0.23353708 |
| 116 | CDK18 | 0.22713273 |
| 117 | MAP3K1 | 0.22395581 |
| 118 | CDK15 | 0.22154108 |
| 119 | RPS6KA1 | 0.21515614 |
| 120 | PNCK | 0.20751284 |
| 121 | MAP3K9 | 0.20404010 |
| 122 | CDK14 | 0.19292816 |
| 123 | PLK1 | 0.18998444 |
| 124 | MAP2K7 | 0.18550104 |
| 125 | STK16 | 0.17171924 |
| 126 | MAP3K10 | 0.16358002 |
| 127 | NLK | 0.15267707 |
| 128 | WNK1 | 0.14304676 |
| 129 | RPS6KC1 | 0.14215332 |
| 130 | RPS6KL1 | 0.14215332 |
| 131 | STK11 | 0.13974760 |
| 132 | MAPK11 | 0.13232510 |
| 133 | CDC42BPA | 0.12839786 |
| 134 | PRKACG | 0.11938930 |
| 135 | RPS6KA6 | 0.10000259 |
| 136 | MTOR | 0.07573372 |
| 137 | EPHB2 | 0.05632022 |
| 138 | RIPK1 | 0.03596367 |
| 139 | PRKDC | 0.03338811 |
| 140 | PRKD1 | 0.03305166 |
| 141 | CSNK1A1 | 0.02832639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.81622008 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 3.75040336 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.53512824 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.94564138 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.89704211 |
| 6 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.69314074 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.50270150 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30331997 |
| 9 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.15836061 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89327456 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88972951 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77090930 |
| 13 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.74685361 |
| 14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.72797364 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70988183 |
| 16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.67315728 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64204992 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58648837 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.58260658 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.56428646 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54413518 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51872638 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49302487 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48045962 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.45931763 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45220693 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44931476 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43281744 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42623027 |
| 30 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40772532 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40273596 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38982943 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.37221679 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37086479 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36890906 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34684582 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33747594 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30994018 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29456555 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.26816406 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.22877761 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.22404291 |
| 43 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.22224145 |
| 44 | Tight junction_Homo sapiens_hsa04530 | 1.19105807 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18385694 |
| 46 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.14666684 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.14569857 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13086315 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11674968 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11172141 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.08488225 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06856728 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02344101 |
| 54 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.01949337 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00963581 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00938666 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.00803886 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.99860088 |
| 59 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99129024 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.98854269 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.98291889 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98163684 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97955447 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95049053 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.94202444 |
| 66 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.92128014 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90725616 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90540187 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90067664 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.89655567 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86161936 |
| 72 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.85847201 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85674751 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85575403 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85232626 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84259165 |
| 77 | Melanoma_Homo sapiens_hsa05218 | 0.84071116 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79440137 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78691540 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76252845 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76031407 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75408530 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.74254889 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.71391608 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.71158840 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70635283 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69930371 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69098189 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68660118 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68659090 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68155847 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.67991697 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67504091 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67346157 |
| 95 | Long-term depression_Homo sapiens_hsa04730 | 0.66593089 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66269842 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.63520998 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61797353 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61202185 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61154193 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61048673 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60916614 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58962817 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58488499 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58370500 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.57414052 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55840237 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.55125696 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52638572 |
| 110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50987069 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50572181 |
| 112 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49523119 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49362365 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48560497 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48502657 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47744538 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46228403 |
| 118 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44971362 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.44889798 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.43964431 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40308762 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.39663746 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37386825 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37358813 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37144743 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36034116 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.34667277 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34278128 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33469131 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29147985 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24423968 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23552172 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22239848 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22118769 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.21571425 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21337868 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.21237920 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14673767 |

